Navigation Links
KineMatik Group Ltd. Appoints Michael G. Jarjour as President & CEO
Date:1/21/2009

Former Organon VP of Global Marketing Will Oversee Life Sciences Software Group

Cork, Ireland (PRWEB) January 21, 2009 - The KineMatik™ Group LTD ("KineMatik"), providers of software solutions for managing scientific R&D knowledge, information and processes, announced that it has appointed Michael G. Jarjour as President & CEO.

Mr. Jarjour, with more than eighteen years of experience in the pharmaceutical research and healthcare technology industries, will lead KineMatik as the company continues to offer leadership and innovation to its pharmaceutical, biotechnology and government clients.

"We are delighted to welcome Michael to the KineMatik team. His extensive experience in sales, marketing, operations and strategic planning, combined with his background and entrepreneurial skills in the life sciences and technology industries, will help us consolidate our position as leaders in the scientific enterprise content of management space," said Harry Lorton, Chairman of the Board of Directors for KineMatik.

"I am pleased to join KineMatik, which has developed an impressive and innovative technology platform," said Mr. Jarjour. "Serving industries so dependent on the rapid, accurate collection of scientific data, KineMatik offers a unique value proposition by supporting secure portfolio, knowledge and project management while lowering costs, increasing productivity and improving time-to-market. In this era of financial and regulatory scrutiny, and intellectual property protection, KineMatik is poised to make a difference in the research and development process."

Before joining KineMatik, Mr. Jarjour was Vice President of Global Marketing for Organon, responsible for leading the $1.5 billion gynecology and urology franchise.

Previously, Mr. Jarjour held key positions at top tier pharmaceutical organizations including Bristol-Myers Squibb, Pharmacia, Warner Lambert and Wyeth. Prior to his work in the pharmaceutical industry, he was the COO and founder of a healthcare technology enterprise for an award-winning, best-in-industry wireless Internet prescribing platform.

Mr. Jarjour holds a BS in Finance from Florida International University and an MBA from the Rutgers University.

About KineMatik: KineMatik brings business methods to the life sciences R&D process, by increasing productivity, accountability and transparency. The company's flagship product, eNovator, is the only software program that lets pharmaceutical, biotechnology and government organizations collaboratively manage their information, knowledge and business processes in one seamlessly integrated and secure system. eNovator, allows researchers to deliver innovation throughout the R&D product development lifecycle. Established in Cork, Ireland in 1999, KineMatik also has offices in London, Princeton, and San Diego. Additional information is available at www.kinematik.com.

Contact:
Jennifer Buchholz
KineMatik
jbuchholz(at)kinematik(dot)com

# # #

Read the full story at http://www.prweb.com/releases/KineMatik_Group/Michael_G_Jarjour/prweb1889204.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. AIM Health Group Inc. and Med-Emerg International Inc. Announce Completion of Previously Disclosed Merger Transaction
2. The Quantum Group Announces Support of Technology Bill Before Congress
3. KJT Group L.L.C. Continues Solid Growth
4. Atlanta Educator Kim Bearden Honored as Healthy Hero by AMERIGROUP Foundation
5. Rochester Medical Announces Settlement With TYCO Healthcare Group, L.P., Now Operating as Covidien Ltd.
6. EBG Advisors and Oldaker Group Form National Health Advisors
7. The Quantum Group and IBM Announce Hosting Agreement for Advanced Healthcare Solutions
8. SOKO Fitness & Spa Group Announces Second Quarter FY2009 Financial Results
9. SOKO Fitness & Spa Group Announces Changes to Previously Issued Financial Statements
10. U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer
11. Med-Emerg International Inc. receives court approval for AIM Health Group arrangement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Orange, NJ (PRWEB) , ... May 24, 2016 , ... ... whiplash that’s causing the problem. A common injury that’s often misunderstood, whiplash should be ... Frazier, MD, a Harvard-trained, orthopedic spine surgeon at Atlantic Spine Center . ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... After graduating ... He spent the next decade in hospitals, on medication, living on Social Security disability ... at the Illness and How I Beat It!” (published by Balboa Press), Alexander shares ...
(Date:5/24/2016)... ... May 24, 2016 , ... Dignity Health has announced ... The new facility is licensed under Dignity Health Arizona General Hospital, which opened ... Dignity Health in Arizona, said that the new facility will complement Dignity Health’s existing ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... high content imaging; multiplex immunoassays are widely used for cell and protein analysis. ... to maximize their quality and efficiency in these areas. , LabRoots introduces a ...
(Date:5/23/2016)... ... 2016 , ... On Sunday, May 15, Rockynol Retirement Community, ... living center. After 18 months of construction, the new state-of-the-art structure was dedicated ... the latest in assisted living amenities and services, offering six different studio and ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 Open ... in Clinical Neurophysiology  Elsevier , a ... and services, today announced the launch of ... access journal that focuses on clinical practice issues in ... reports, clinical series, normal values and didactic reviews. It ...
(Date:5/23/2016)... PUNE, India , May 23, 2016 /PRNewswire/ ... research report "Patient Handling Equipment Market by Product ... Type of Care (Bariatric Care, Critical Care, Wound), ... Hospital) - Forecast to 2021", published by MarketsandMarkets, ... reach USD 17.18 Billion by 2021 at a ...
(Date:5/23/2016)... ALBANY, New York , May 23, 2016 /PRNewswire/ ... new market report titled, " Exocrine Pancreatic Insufficiency Market ... Forecast 2013 - 2023 ." According to the report, ... at a CAGR of 8.3% from 2015 to 2023 ... pancreatic insufficiency (EPI) is a condition characterized by the ...
Breaking Medicine Technology: